Spots Global Cancer Trial Database for prognostic
Every month we try and update this database with for prognostic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Determining Prognostic Immune Markers in Patients With Ovarian Cancer | NCT03862677 | Epithelial Ovar... | No intervention | 18 Years - | Leiden University Medical Center | |
| Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX | NCT03590275 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | Azienda Ospedaliero, Universitaria Pisana | |
| Analysis of Palliative Surgery in View of Quality of Life and Prognosis | NCT00690391 | Cancer Quality of Life | - | Johann Wolfgang Goethe University Hospital | ||
| Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma | NCT03090815 | Adenocarcinoma ... | Sequencing of c... | 18 Years - 80 Years | The University of Hong Kong | |
| Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer | NCT03513198 | Pancreas Cancer | Endoscopic ultr... Contrast-enhanc... Endoscopic ultr... Contrast-enhanc... | 18 Years - 90 Years | University of Medicine and Pharmacy Craiova | |
| Tumor Molecular Profiling in Patients With Prostate Cancer | NCT05573789 | Prostate Cancer Metastatic Pros... | Tumor molecular... | 18 Years - | Hellenic Cooperative Oncology Group | |
| Tumor Molecular Profiling in Patients With Prostate Cancer | NCT05573789 | Prostate Cancer Metastatic Pros... | Tumor molecular... | 18 Years - | Hellenic Cooperative Oncology Group | |
| Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor. | NCT04625491 | Cutaneous Melan... Anatomical Path... | Observational | - | Hospital Universitario Virgen de la Arrixaca | |
| Tumor Molecular Profiling in Patients With Prostate Cancer | NCT05573789 | Prostate Cancer Metastatic Pros... | Tumor molecular... | 18 Years - | Hellenic Cooperative Oncology Group | |
| Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX | NCT03590275 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | Azienda Ospedaliero, Universitaria Pisana | |
| Identification of New Prognostic Markers for Breast Cancer. | NCT03436069 | Breast Cancer | Conventional tr... | 18 Years - | University Hospital, Grenoble | |
| Prognosis of Signet Ring Cells in Upper Digestive Neoplasms | NCT01249859 | Signet Ring Cel... Stomach Disease Oesophagus Prognostic Case-control St... | 18 Years - 95 Years | University Hospital, Lille | ||
| Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer | NCT00298064 | Cervical Cancer Cervix | Tissue Reposito... | - | University of New Mexico | |
| Surgical Resection for Hepatocellular Carcinoma | NCT06013657 | Resectable Hepa... | Liver Resection | - | Dr Cipto Mangunkusumo General Hospital | |
| Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma | NCT03471897 | Renal Cell Carc... | Glycosaminoglyc... | 18 Years - | Chalmers University of Technology | |
| Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer | NCT03724994 | Periampullary A... Periampullary C... Pancreatic Canc... | Gemcitabine | 18 Years - | Lund University | |
| Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX | NCT03590275 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | Azienda Ospedaliero, Universitaria Pisana | |
| Echocardiography for RILI Prediction | NCT02501707 | NSCLC | 18 Years - | Maastricht Radiation Oncology | ||
| Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study | NCT04935853 | Biliary Tract C... | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | ||
| Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma | NCT06430424 | Relapsed Cancer Glioblastoma ID... | Relapsed gliobl... | 18 Years - | University Hospital, Bordeaux | |
| AML-MDS Novel Prognostic Tests Clinical Study | NCT01685619 | Acute Myeloid L... Myelodysplastic... | 18 Years - | Nova Scotia Health Authority | ||
| AML-MDS Novel Prognostic Tests Clinical Study | NCT01685619 | Acute Myeloid L... Myelodysplastic... | 18 Years - | Nova Scotia Health Authority | ||
| Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma | NCT06430424 | Relapsed Cancer Glioblastoma ID... | Relapsed gliobl... | 18 Years - | University Hospital, Bordeaux |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
